Skip to main content
Premium Trial:

Request an Annual Quote

Cancer's "Moonshot"

Premium

Ron DePinho, the new president of the MD Anderson Cancer Center in Houston, hopes to cure five types of cancer — a feat that DePinho acknowledges is a "moonshot," reports The Economist. Which five cancers to tackle hasn't been decided yet, but The Economist says that the effort would only be possible because of the International Cancer Genome Consortium, which is working to thoroughly sequence the genomes of 50 cancer types. At MD Anderson, DePinho wants to "'industrialize' other aspects of biological research in the way that genetics has been pushed forward by high-throughput sequencing," The Economist says.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.